Publications by authors named "Marina Parton"

Claim this Profile
T
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study.
Matilde Corianò, Chiara Tommasi, Anh Thi Lan Dinh, Jazmine Needham, Hala Aziz, Marina Parton

Breast Cancer Res Treat· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinical Features and Outcomes of Pseudocirrhosis in Breast Cancer.
Edward Phillips, Mantegh Sethi, Surammiya Vasanthakumar, Gina Sherpa, Stephen Johnston, Marina Parton

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives.
Dione Lother, Marie Robert, Elliot Elwood, Sam Smith, Nina Tunariu, Marina Parton

Cancer Imaging· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vinorelbine After Prior Treatment With Eribulin for Advanced Breast Cancer: A Single-Centre Experience Suggesting Cross-Resistance.
Alicia F C Okines, Tazia Irfan, Kabir Mohammed, Alistair Ring, Marina Parton

Clin Breast Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital.
Niamh Cunningham, Scott Shepherd, Kabir Mohammed, Karla A Lee, Mark Allen, Marina Parton

Breast Cancer Res Treat· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review on the added value of whole-body MRI in metastatic lobular breast cancer.
Basrull N Bhaludin, Nina Tunariu, Dow-Mu Koh, Christina Messiou, Alicia F Okines, Marina M Parton

Eur Radiol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience.
Alicia Okines, Tazia Irfan, Bernice Asare, Kabir Mohammed, Peter Osin, Marina Parton

Breast Cancer Res Treat· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous toxicities occurring during palbociclib (CDK4/6 inhibitor) and endocrine therapy in patients with advanced breast cancer: a single-centre experience.
Sumir Chawla, Alison Hill, Louise Fearfield, Stephen Johnston, Marina Parton

Breast Cancer Res Treat· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of timing of adjuvant chemothapy for early breast cancer: the Royal Marsden Hospital experience.
Alicia F C Okines, Emma Kipps, Tazia Irfan, Maria Coakley, Vaselios Angelis, Marina Parton

Br J Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of T-DM1 in patients with advanced HER2-positive breast cancer The Royal Marsden experience.
Nicolò Matteo Luca Battisti, Frances Rogerson, Karla Lee, Scott Shepherd, Kabir Mohammed, Marina Parton

Cancer Treat Res Commun· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience.
Valerie E Crolley, Husam Marashi, Shabbir Rawther, Bhawna Sirohi, Marina Parton

Breast Cancer Res Treat· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivating Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance.
Alex Pearson, Paula Proszek, Javier Pascual, Charlotte Fribbens, Monee K Shamsher, Marina Parton

Clin Cancer Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experience.
Nicolò Matteo Luca Battisti, Victoria True, Narda Chaabouni, Neha Chopra, Karla Lee, Marina Parton

Breast Cancer Res Treat· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial.
Aditya Bardia, Marina Parton, Sherko Kümmel, Laura G Estévez, Chiun-Sheng Huang

J Clin Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experience.
Alicia Okines, Tazia Irfan, Komel Khabra, Ian Smith, Mary O'Brien, Marina Parton

Breast J· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing.
Anna Schuh, Helene Dreau, Samantha J L Knight, Kate Ridout, Tuba Mizani, Marina Parton

Cold Spring Harb Mol Case Stud· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer.
Andrew Dodson, David Okonji, Laura Assersohn, Anne Rigg, Amna Sheri, Marina Parton

Breast Cancer Res Treat· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
Belinda Kingston, Hamzeh Kayhanian, Chloe Brooks, Nicola Cox, Narda Chaabouni, Marina Parton

Breast· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Follow-up Data from Pivotal Studies of Adjuvant Trastuzumab in Early Breast Cancer.
Hartmut Kristeleit, Marina Parton, Mark Beresford, Iain R Macpherson, Rajan Sharma

Target Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive detection of HER2 amplification with plasma DNA digital PCR.
Heidrun Gevensleben, Isaac Garcia-Murillas, Monika K Graeser, Gaia Schiavon, Peter Osin, Marina Parton

Clin Cancer Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of ipsilateral breast radiotherapy in management of occult primary breast cancer presenting as axillary lymphadenopathy.
Sarah R Barton, Ian E Smith, Anna M Kirby, Sue Ashley, Geraldine Walsh, Marina Parton

Eur J Cancer· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer.
Monika Graeser, Afshan McCarthy, Christopher J Lord, Kay Savage, Margaret Hills, Marina Parton

Clin Cancer Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer.
Robin L Jones, Janine Salter, Roger A'Hern, Ash Nerurkar, Marina Parton

Breast Cancer Res Treat· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer.
Robin L Jones, Janine Salter, Roger A'Hern, Ash Nerurkar, Marina Parton

Breast Cancer Res Treat· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women.
Marina Parton, Ian E Smith

J Clin Oncol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis